RNTX Rein Therapeutics, Inc.

Fundamentals / CIK 0001420565 / USD

Rein Therapeutics, Inc. reported $0 in revenue and a net loss of $49.72M for the trailing twelve months ended September 30, 2026.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open RNTX in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$0$0$0-$58.80MFY 2016 Revenue: $0FY 2016 Net Income: -$18.12M2016FY 2017 Revenue: $0FY 2017 Net Income: -$22.60M2017FY 2018 Revenue: $0FY 2018 Net Income: -$31.55M2018FY 2019 Revenue: $0FY 2019 Net Income: -$29.37M2019FY 2020 Revenue: $0FY 2020 Net Income: -$27.33M2020FY 2021 Revenue: $0FY 2021 Net Income: -$26.16M2021FY 2022 Revenue: $0FY 2022 Net Income: -$27.33M2022FY 2023 Revenue: $0FY 2023 Net Income: -$15.73M2023FY 2024 Revenue: $0FY 2024 Net Income: -$62.88M2024FY 2025 Revenue: $0FY 2025 Net Income: -$49.87M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $0 $0 $0 $0 $0 $0 $0 $0 $0 $0
Research & Development $11.03M $14.25M $3.99M $17.97M $17.01M $11.17M $17.66M $18.45M $14.24M $10.28M
Total Operating Expenses $50.63M $65.11M $16.28M $27.65M $26.61M $20.50M $29.96M $31.90M $23.01M $18.17M
Operating Income -$50.63M -$65.11M -$16.28M -$27.65M -$26.61M -$20.50M -$29.96M -$31.90M -$23.01M -$18.17M
EBITDA -$50.63M -$65.05M -$16.16M -$27.48M -$26.48M -$20.33M -$29.80M -$31.68M -$22.88M -$17.94M
Income Tax Expense -$712K -$1.54M $0 $0 $0 $0 $0 $0 $0 $0
Net Income -$49.87M -$62.88M -$15.73M -$27.33M -$26.16M -$27.33M -$29.37M -$31.55M -$22.60M -$18.12M
Basic EPS -$1.96 -$3.51 -$3.42 -$6.02 -$117.80 -$12.20 -$24.00 -$42.80 -$60.80 -$847.00
Diluted EPS -$1.96 -$3.51 -$3.42 -$6.02 -$117.80 -$12.20 -$24.00 -$42.80 -$60.80 -$847.00
Basic Shares Outstanding 25.4M 17.9M 4.6M 4.5M 222.0K 1.7M 1.2M 736.9K 372.2K 21.5K
Diluted Shares Outstanding 25.4M 17.9M 4.6M 4.5M 222.0K 1.7M 1.2M 736.9K 372.2K 21.5K

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $0 $0 $0 $0 $0 $0 $0 $0
Research & Development $4.38M $3.64M $3.07M $2.00M $1.68M $4.29M $3.05M $3.32M
Total Operating Expenses $7.00M $6.08M $5.23M $32.66M $5.49M $6.87M $5.61M $42.80M
Operating Income -$7.00M -$6.08M -$5.23M -$32.66M -$5.49M -$6.87M -$5.61M -$42.80M
EBITDA -- -- -- -$32.66M -$5.49M -$6.87M -$5.61M -$42.80M
Net Income -$5.54M -$6.38M -$5.84M -$31.97M -$5.58M -$6.82M -$5.50M -$40.98M
Basic EPS -$0.06 -$0.10 -$0.19 -- -$0.21 -$0.28 -$0.25 --
Diluted EPS -$0.06 -$0.10 -$0.19 -- -$0.21 -$0.28 -$0.25 --
Basic Shares Outstanding 88.3M 67.1M 30.4M -- 26.4M 24.2M 21.9M --
Diluted Shares Outstanding 88.3M 67.1M 30.4M -- 26.4M 24.2M 21.9M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $3.21M $12.87M $17.34M $5.19M $3.60M $7.05M $5.31M $10.63M $11.86M $20.71M
Short-Term Investments $0 -- -- $16.05M $42.33M $6.76M $12.97M $10.06M $38.89M $0
Cash & Short-Term Investments $3.21M $12.87M $17.34M $21.24M $45.93M $13.80M $18.28M $20.70M $50.75M $20.71M
Other Current Assets $881K $676K $675K $606K -- -- -- -- -- --
Total Current Assets $4.33M $13.66M $18.27M $21.87M $48.18M $16.33M $19.55M $21.77M $51.84M $21.07M
Property, Plant & Equipment, Net $0 $1.0K $19K $70K $128K $15K $295K $7.29M $154K $107K
Goodwill $6.33M $6.33M $6.33M -- -- -- -- -- -- --
Intangible Assets $13.50M $42.20M $79.20M -- -- -- -- -- -- --
Long-Term Investments $0 -- -- -- -- -- -- -- -- --
Other Non-Current Assets $2.0K $2.0K $2.19M $24K $24K -- -- $679K $694K $778K
Total Non-Current Assets $19.83M $48.53M $87.74M $134K $304K $15K $6.92M $8.54M $848K $948K
Total Assets $24.16M $62.19M $106.0M $22.01M $48.48M $16.34M $26.47M $30.31M $52.69M $22.02M
Accounts Payable $3.98M $911K $1.19M $1.72M $1.21M $1.60M $1.45M $1.73M $1.60M $1.97M
Total Current Liabilities $6.18M $5.75M $4.38M $3.38M $4.51M $3.96M $5.84M $5.37M $4.89M $4.07M
Other Non-Current Liabilities $0 $277K -- -- -- -- -- -- -- --
Total Non-Current Liabilities $1.06M $2.05M $3.33M $0 $69K $219K $4.59M $5.34M $0 $11K
Total Liabilities $7.24M $7.80M $7.71M $3.38M $4.58M $4.18M $10.43M $10.71M $4.89M $4.08M
Total Debt (incl. Leases) -- -- $48K $48K $162K -- $5.03M $5.40M -- --
Common Stock $113K $108K $91K $91K $91K $44K $28K $15K $15K $0
Retained Earnings -$401.3M -$351.4M -$288.5M -$272.8M -$245.5M -$219.3M -$198.1M -$168.5M -$136.9M -$114.3M
Accumulated Other Comp. Income -$62K -$18K -$63K -$48K -$13K -$2.0K $7.0K -$5.0K -$33K --
Total Stockholders' Equity $16.92M $54.39M $98.30M $18.62M $43.90M $12.16M $16.05M $19.60M $47.80M -$111.8M
Total Equity $16.92M $54.39M $98.30M $18.62M $43.90M $12.16M $16.05M $19.60M $47.80M -$111.8M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $943K $8.54M $4.45M $3.21M $4.05M $5.72M $7.43M $12.87M
Short-Term Investments $34.55M $32.10M -- $0 -- -- -- --
Cash & Short-Term Investments $36.49M $43.63M $4.45M $3.21M $4.05M $5.72M $7.43M $12.87M
Other Current Assets $1.23M $727K $918K $881K $997K $692K $864K $676K
Total Current Assets $36.78M $41.45M $5.45M $4.33M $5.17M $6.60M $8.33M $13.66M
Property, Plant & Equipment, Net -- -- -- $0 $0 $1.0K $1.0K $1.0K
Goodwill $6.33M $6.33M $6.33M $6.33M $6.33M $6.33M $6.33M $6.33M
Intangible Assets $13.50M $13.50M $13.50M $13.50M $42.20M $42.20M $42.20M $42.20M
Long-Term Investments $994K $2.98M -- $0 -- -- -- --
Other Non-Current Assets $1.82M $1.71M $1.00M $2.0K $2.0K $2.35M $766K $2.0K
Total Non-Current Assets $22.64M $24.52M $20.84M $19.83M $48.53M $50.88M $49.30M $48.53M
Total Assets $59.43M $65.97M $26.29M $24.16M $53.71M $57.48M $57.63M $62.19M
Accounts Payable $3.20M $4.47M $6.26M $3.98M $4.12M $6.03M $1.15M $911K
Total Current Liabilities $5.60M $9.71M $13.64M $6.18M $5.74M $7.69M $5.98M $5.75M
Other Non-Current Liabilities -- -- -- $0 $0 $0 $0 $277K
Total Non-Current Liabilities $1.06M $1.06M $1.06M $1.06M $1.77M $1.77M $1.77M $2.05M
Total Liabilities $6.66M $10.77M $14.70M $7.24M $7.52M $9.47M $7.75M $7.80M
Common Stock $172K $172K $114K $113K $111K $109K $108K $108K
Retained Earnings -$419.0M -$413.5M -$407.1M -$401.3M -$369.3M -$363.7M -$356.9M -$351.4M
Accumulated Other Comp. Income -$115K -$69K -$62K -$62K -$44K -$44K -$32K -$18K
Total Stockholders' Equity $52.77M $55.20M $11.59M $16.92M $46.19M $48.01M $49.88M $54.39M
Total Equity $52.77M $55.20M $11.59M $16.92M $46.19M $48.01M $49.88M $54.39M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$49.87M -$62.88M -$15.73M -$27.33M -$26.16M -$21.16M -$29.37M -$31.55M -$22.60M -$18.12M
Depreciation & Amortization $1.0K $63K $119K $169K $121K $163K $155K $218K $129K $232K
Stock-Based Compensation $2.22M $1.12M $1.19M $2.08M $2.26M $1.89M $2.12M $3.28M $1.75M $688K
Change in Payables $3.06M -$279K -$4.98M $510K -$386K $116K -$277K $130K -$241K $1.22M
Operating Cash Flow -$19.36M -$22.29M -$19.81M -$24.86M -$23.75M -$20.48M -$26.47M -$27.93M -$20.53M -$15.01M
Capital Expenditure -- -- -- -- -$157K -$5.0K -$151K -$4.42M -$142K --
Free Cash Flow -- -- -- -- -$23.91M -$20.48M -$26.62M -$32.35M -$20.67M --
Acquisitions, Net -- $0 -$96K $0 -- -- -- -- -- --
Purchases of Investments -- -- -- -$21.85M -$73.58M -$10.03M -$27.24M -$31.19M -$71.06M -$12.63M
Investing Cash Flow -- $0 $16.20M $26.46M -$35.92M $6.41M -$2.81M $24.69M -$38.91M -$25K
Common Stock Issued $1.82M $10.64M $0 -- -- $16.88M -- -- -- --
Financing Cash Flow $9.76M $17.82M $15.79M -- $55.66M $15.80M $23.96M $2.52M $50.59M $31.99M
Net Change in Cash -$9.65M -$4.47M $12.12M $1.59M -$4.01M $1.74M -$5.32M -$723K -$8.85M $16.95M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$5.54M -$6.38M -$5.84M -$31.97M -$5.58M -$6.82M -$5.50M -$40.98M
Depreciation & Amortization -- -- -- $0 $0 $1.0K $0 $0
Stock-Based Compensation $534K $164K $156K $257K $1.45M $256K $264K $133K
Change in Payables -$1.27M -$1.89M $2.29M -$147K -$1.91M $4.88M $238K -$168K
Operating Cash Flow -$7.27M -$8.64M -$3.42M -$3.22M -$3.55M -$6.42M -$6.17M -$4.81M
Investing Cash Flow -- -- -- -- -- -- -- $0
Common Stock Issued $0 $53.19M $354K -$448K $1.90M -$370K $737K $0
Financing Cash Flow $0 $47.81M $4.65M $2.40M $1.90M $4.71M $738K $1.0K
Net Change in Cash -$7.60M $4.10M $1.23M -$833K -$1.67M -$1.71M -$5.44M -$4.81M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Return on Equity (ROE) -294.8% -115.6% -16.0% -146.7% -59.6% -224.7% -183.0% -161.0% -47.3% --
Return on Assets (ROA) -206.4% -101.1% -14.8% -124.2% -54.0% -167.2% -110.9% -104.1% -42.9% -82.3%
Current Ratio 0.70x 2.38x 4.17x 6.46x 10.69x 4.12x 3.35x 4.05x 10.60x 5.18x
Quick Ratio 0.52x 2.24x 3.95x 6.28x 10.19x 3.49x 3.13x 3.85x 10.38x 5.09x
Debt to Equity -- -- 0.00x 0.00x 0.00x -- 0.31x 0.28x -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -94.2% -90.1% -433.2% -294.8% -127.5% -123.2% -122.8% -115.6%
Return on Assets (ROA) -83.7% -75.4% -191.0% -206.4% -109.6% -102.9% -106.3% -101.1%
Current Ratio 6.57x 4.27x 0.40x 0.70x 0.90x 0.86x 1.39x 2.38x
Quick Ratio 6.52x 4.49x 0.33x 0.52x 0.70x 0.74x 1.24x 2.24x
Source: SEC EDGAR CompanyFacts (CIK 0001420565) · from December 31, 2015 Data through September 30, 2026 · synced Nov 20, 2026, 05:52 UTC · Open in terminal